| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
230,290,000 |
| Market
Cap: |
138.17(K) |
| Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,580 |
| 52
Week Range: |
$0.0001 - $0.066 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kimmel Roger H |
Director |
– • – |
2008-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,723 |
172,126 |
|
- |
|
| Holveck David |
President & CEOOfficer |
• • – |
2008-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
46,088 |
|
- |
|
| Meanwell Clive |
Director |
– • – |
2008-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,741 |
5,003 |
|
- |
|
| De Rosen Michel |
Director |
– • – |
2008-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,741 |
5,003 |
|
- |
|
| Horner George F III |
Director |
– • – |
2008-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,741 |
5,003 |
|
- |
|
| Hyatt Michael |
Director |
– • – |
2008-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,741 |
250,753 |
|
- |
|
| Delucca John |
Director |
– • – |
2008-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,741 |
5,003 |
|
- |
|
| Kimmel Roger H |
Director |
– • – |
2008-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,741 |
170,403 |
|
- |
|
| Rowland Charles A Jr |
EVP, CFO & Treasurer |
• – – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
6,699 |
6,699 |
|
- |
|
| Wysenski Nancy |
Chief Operating Officer |
• – – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,466 |
4,466 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,583 |
5,583 |
|
- |
|
| Lee David A H |
Exec. V.P and CSO |
• – – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,801 |
2,801 |
|
- |
|
| Laviscount Joyce N |
Chief Accounting Officer |
• – – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,275 |
3,275 |
|
- |
|
| Lee David A H |
Exec. V.P and CSO |
• – – |
2007-12-14 |
4 |
A |
$0.00 |
$0 |
I/I |
109,305 |
185,754 |
|
- |
|
| Lee David A H |
Exec. V.P and CSO |
• – – |
2007-12-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(109,305) |
185,754 |
|
- |
|
| Lee David A H |
Exec. V.P and CSO |
• – – |
2007-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
109,305 |
185,754 |
|
- |
|
| Lee David A H |
Exec. V.P and CSO |
• – – |
2007-08-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(109,305) |
185,754 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2007-07-03 |
4 |
AS |
$34.90 |
$2,082,134 |
D/D |
(59,660) |
293,702 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2007-07-03 |
4 |
OE |
$9.17 |
$553,382 |
D/D |
59,660 |
0 |
|
- |
|
| Horner George F III |
Director |
– • – |
2007-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,262 |
2,262 |
|
- |
|
| Kimmel Roger H |
Director |
– • – |
2007-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,262 |
2,262 |
|
- |
|
| Meanwell Clive |
Director |
– • – |
2007-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,262 |
2,262 |
|
- |
|
| Delucca John |
Director |
– • – |
2007-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,262 |
2,262 |
|
- |
|
| De Rosen Michel |
Director |
– • – |
2007-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,262 |
2,262 |
|
- |
|
| Hyatt Michael |
Director |
– • – |
2007-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,262 |
2,262 |
|
- |
|
825 Records found
|
|
Page 14 of 33 |
|
|
